David Scadden - Director at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Scadden since 11/21/2023

Holdings reported by David Scadden for Agios Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 15.5K $756K $48.84 Jun 13, 2024 Direct
Restricted stock units 2.12K $104K $48.84 Jun 20, 2024 Direct Common stock
Stock options (right to buy) 11.8K Jun 20, 2024 Direct Common stock

Transactions reported by David Scadden for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.